Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00004451 · ClinicalTrials.gov registry record · NA

Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients

A NA study of Parkinson Disease, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT00004451 is a NA study of Parkinson Disease that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 120 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00004451, a NA study of Parkinson Disease, has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This study will determine whether glucose facilitates memory in healthy elderly people and those with Parkinson's disease.

Conditions Studied

Interventions

  • DRUG Glucose

Study Locations (1)

Virginia

  • University of Virginia - Charlottesville

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 1998-03
Phase NA

What the Registry Record Tells You About NCT00004451

The ClinicalTrials.gov registry entry for NCT00004451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (98% lower). The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Glucose is the first listed.

NCT00004451 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.

Frequently Asked Questions

What is clinical trial NCT00004451 about?

NCT00004451 is a clinical study titled "Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease Patients". This study will determine whether glucose facilitates memory in healthy elderly people and those with Parkinson's disease.

What is the current status of trial NCT00004451?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 1998-03.

What conditions does trial NCT00004451 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT00004451?

The interventions under investigation include: Glucose (DRUG).

Who is sponsoring clinical trial NCT00004451?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00004451 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.